These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 23257758)
1. [The comparative study on the efficacy of the combination of serotonin reuptake inhibitor antidepressants and antipsychotics in the treatment of recurrent depressive disorders]. D'iakonov AL; Lobanova IV Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(11 Pt 2):61-6. PubMed ID: 23257758 [TBL] [Abstract][Full Text] [Related]
2. [Efficacy of atypical antipsychotics in depressive syndromes]. Quintin P; Thomas P Encephale; 2004; 30(6):583-9. PubMed ID: 15738862 [TBL] [Abstract][Full Text] [Related]
3. Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine. Molina JD; Toledo-Romero F; López-Rodríguez E; Amorin-Díaz M; Lerma-Carrillo I; López-Muñoz F Pharmacopsychiatry; 2011 Jun; 44(4):142-7. PubMed ID: 21710404 [TBL] [Abstract][Full Text] [Related]
4. Does olanzapine have any antidepressant effect? Moreira-Almeida A; Pietrobon R Am J Psychiatry; 2006 Oct; 163(10):1838-9; author reply 1839. PubMed ID: 17012700 [No Abstract] [Full Text] [Related]
5. A double-blind, randomised comparative trial of amisulpride versus olanzapine in the treatment of schizophrenia: short-term results at two months. Martin S; Lĵo H; Peuskens J; Thirumalai S; Giudicelli A; Fleurot O; Rein W; Curr Med Res Opin; 2002; 18(6):355-62. PubMed ID: 12442883 [TBL] [Abstract][Full Text] [Related]
6. [Olanzapine: a second generation antipsychotic drug and an "atypical" mood stabilizer?]. Bánki CM Psychiatr Hung; 2007; 22(4):311-20. PubMed ID: 18167425 [TBL] [Abstract][Full Text] [Related]
7. Successful treatment of anorexia with a combination of high-dose olanzapine, fluoxetine and mirtazapine. Fountoulakis KN; Iacovides A; Siamouli M; Koumaris V; Kaprinis GS Int J Clin Pharmacol Ther; 2006 Sep; 44(9):452-3. PubMed ID: 16995335 [No Abstract] [Full Text] [Related]
8. Amisulpride versus olanzapine in the treatment of schizophrenia in Indian patients: randomized controlled trial. Bhowmick S; Hazra A; Ghosh M Aust N Z J Psychiatry; 2010 Mar; 44(3):237-42. PubMed ID: 20050717 [TBL] [Abstract][Full Text] [Related]
9. Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs amisulpride. Wagner M; Quednow BB; Westheide J; Schlaepfer TE; Maier W; Kühn KU Neuropsychopharmacology; 2005 Feb; 30(2):381-90. PubMed ID: 15578006 [TBL] [Abstract][Full Text] [Related]
10. Hyperpigmentation with amisulpride. Mendhekar DN Aust N Z J Psychiatry; 2009 Jan; 43(1):88. PubMed ID: 19086350 [No Abstract] [Full Text] [Related]
11. Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies. Tohen M; Case M; Trivedi MH; Thase ME; Burke SJ; Durell TM J Clin Psychiatry; 2010 Apr; 71(4):451-62. PubMed ID: 20361905 [TBL] [Abstract][Full Text] [Related]
13. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. Kroenke K; West SL; Swindle R; Gilsenan A; Eckert GJ; Dolor R; Stang P; Zhou XH; Hays R; Weinberger M JAMA; 2001 Dec; 286(23):2947-55. PubMed ID: 11743835 [TBL] [Abstract][Full Text] [Related]
14. Influence of fluoxetine on olanzapine pharmacokinetics. Gossen D; de Suray JM; Vandenhende F; Onkelinx C; Gangji D AAPS PharmSci; 2002; 4(2):E11. PubMed ID: 12102620 [TBL] [Abstract][Full Text] [Related]
15. Antipsychotics possessing antidepressive efficacy increase Golf protein in rat striatum. Taoka H; Hamamura T; Endo S; Miyata S; Toma K; Ishihara T; Kuroda S Psychopharmacology (Berl); 2008 Dec; 201(2):229-35. PubMed ID: 18777019 [TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study. Maina G; Vitalucci A; Gandolfo S; Bogetto F J Clin Psychiatry; 2002 Jan; 63(1):38-43. PubMed ID: 11838624 [TBL] [Abstract][Full Text] [Related]
17. A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression. Corya SA; Perlis RH; Keck PE; Lin DY; Case MG; Williamson DJ; Tohen MF J Clin Psychiatry; 2006 May; 67(5):798-806. PubMed ID: 16841630 [TBL] [Abstract][Full Text] [Related]
18. Serotonin reuptake inhibitor provoked recurrence of alcohol hallucinosis--remission with additive amisulpride medication. A case report. Hermann D; Heinz A; Croissant B; Mann K Pharmacopsychiatry; 2004 Mar; 37(2):90-2. PubMed ID: 15048618 [No Abstract] [Full Text] [Related]
19. [Psychotropic drugs used in a psychiatric hospital (pharmaco-epidemiologic aspects)]. Kozyrev VN; Smulevich AB; Drobizhev MIu; Kraeva GK; Kubrakov MA Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):25-32. PubMed ID: 14681962 [TBL] [Abstract][Full Text] [Related]
20. Olanzapine augmentation of fluoxetine in body dysmorphic disorder. Phillips KA Am J Psychiatry; 2005 May; 162(5):1022-3. PubMed ID: 15863817 [No Abstract] [Full Text] [Related] [Next] [New Search]